| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 20 Billion | USD 35.66 Billion | 7.50% | 2024 |
FrequentlyAsked Questions
Drug addiction treatment comprises a wide range of psychological and medical approaches designed to help patients regain control of their lives and overcome substance dependence. Standard treatments like medication-assisted treatments, behavioral therapies, counselling, and more, aim to reduce withdrawal symptoms, address underlying mental health issues, and prevent relapse.
The global drug addiction treatment market is projected to grow due to growing incidences of substance use disorders, the rise in detox and rehabilitation centers, and improvements in addiction therapy.
According to study, the global drug addiction treatment market size was worth around USD 20 billion in 2024 and is predicted to grow to around USD 35.66 billion by 2034.
The CAGR value of the drug addiction treatment market is expected to be around 7.50% during 2025-2034.
North America is expected to lead the global drug addiction treatment market during the forecast period.
The key players profiled in the global drug addiction treatment market include Alkermes plc, Indivior PLC, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Opiant Pharmaceuticals, Hikma Pharmaceuticals, Cipla Ltd., Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries Ltd., Novartis AG, Amneal Pharmaceuticals, Inc., Glenmark Pharmaceuticals, Camurus AB, and Emergent BioSolutions Inc.
Market trends in drug addiction treatment are shifting toward digital therapeutics, personalized therapies, and medication-assisted treatments. Consumer preferences are increasingly favoring telehealth services, outpatient programs, and holistic recovery approaches.
HappyClients